KOURTNEY KARDASHIAN AND TRAVIS BARKER MAKE RARE RED CARPET RETURN AT TRIBECA FILM FESTIVAL DATE NIGHT. (PHOTO).

Image
 Kourtney Kardashian and Travis Barker make rare red carpet return at Tribeca Film Festival date night Kourtney Kardashian and Travis Barker made a rare joint appearance on Saturday night, stepping out together at the Tribeca Film Festival for a date night in New York City. The couple returned to the red carpet for the first time in over two years as they attended the premiere of Barker’s documentary, Travis Barker: Louder Than Fear. They arrived in coordinated black outfits, presenting a sleek, unified look for the evening. Kardashian, 47, wore a long-sleeved satin gown featuring a white collar and button detailing down the front.  The outfit included a high slit that revealed her legs, and she layered a black bralette underneath. She completed the look with black pointed heels and a satin clutch, wearing her hair down with straight bangs framing her face. Barker, 50, kept his style classic in a black suit, finishing the outfit with dark square sunglasses.  He was also j...

CHINESE COVID-19 VACCINE SHOWS PROMISING RESULTS.[PHOTO}.

Chinese COVID-19 vaccine shows promising results - CGTN
   We are all expecting a COVID-19 vaccine that could possibly end the pandemic that has killed more than 330,000 people.
Now the first vaccine candidate from China has finished its phase-1 trial on humans, and the results have been put online for everyone to examine.
The Lancet, a respected medical journal in the UK, published the results on Friday saying it is "safe" and "induces rapid immune response."
The research injected the potential vaccine into 108 volunteers.
They were divided into three groups, each taking a different dose of the vaccine.
The vaccine, classified as "recombinant adenovirus type-5 vectored" (Ad5-nCoV), acts as a natural infection and is especially good at teaching the immune system how to fight the virus.During the next 28 days, no serious reactions were found, meaning the vaccine seemed to be tolerable by humans.Also, antibodies against the SARS-CoV-2 started to surge two weeks after the injection and reached its peak on day 28.The vaccine "warrants further investigation," the paper on The Lancet concluded.A phase-2 clinical trial has started with 508 volunteers involved.The trial was conducted by a team led by Chen Wei, a biology professor from Academy of Military Medical Sciences and a member of the Chinese Academy of Engineering.There are other two vaccines allowed for human trials in China. They are ShaCoVacc and PiCoVacc.-CCTV.
Chinese COVID-19 vaccine shows promising results - CGTN

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).